Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Qoria rejects acquisition proposal from US private investment firm K1, cites undervaluation
    • News

    Qoria rejects acquisition proposal from US private investment firm K1, cites undervaluation

    Australian cyber safety company Qoria (ASX: QOR) has promptly rejected an unsolicited acquisition proposal from US-based private investment firm K1 Investment Management.  The conditional and non-binding offer is to acquire 100% of Qoria’s issued share capital for $0.40 cash per Qoria share through a scheme of arrangement.  The Indicative Proposal was subject to conditions including

    Read More
    Public
  • US shares rebound with strong jobs data, XJO to rise on open
    • Market Update

    US shares rebound with strong jobs data, XJO to rise on open

    The XJO is expected to rally on open this morning following a strong rebound in the U.S on Friday which saw their market move back above their key support. Their futures are also in the green. On Friday we managed to retake almost half of the intraday losses by close as we rebounded off key

    Read More
    Public
  • Chimeric Therapeutics granted US patent for its blood cancer technology
    • News

    Chimeric Therapeutics granted US patent for its blood cancer technology

    The United States Patent and Trademark Office (USPTO) has recently granted a patent to Australia-based clinical-stage cell therapy company Chimeric Therapeutics (ASX: CHM) for its CHM 0201 (CORE-NK) technology, which targets blood cancers and solid tumours.  The technology is used in the production of Chimeric’s clinical-stage universal NK cell asset CHM 0201, as well as

    Read More
    Public
  • Monthly Economic Wrap: Rate cuts, a Chinese nuclear arsenal and impending TikTok ban
    • News

    Monthly Economic Wrap: Rate cuts, a Chinese nuclear arsenal and impending TikTok ban

    Global markets rose through March 2024 in the backdrop of President Joe Biden and Fed Chair Jerome Powell agreeing that rate cuts would be seen in 2024. But it wouldn’t be a US election year without political tensions simmering across the seas with the US set to ban TikTok in the country. Separately, a top

    Read More
    Public
  • US shares fall on hawkish FED comments, XJO to reverse yesterday’s gains
    • Market Update

    US shares fall on hawkish FED comments, XJO to reverse yesterday’s gains

    The XJO is expected to open lower this morning following a big selloff in the U.S overnight. Their futures are flat. We should wipe off yesterday’s relief rally and continue the decent we started on Wednesday. 7,750 support will be tested on open this morning, and will likely fail. 7,700 is the next key level

    Read More
    Public
  • Small cap MD buys $1 million of shares with no discount as business transformation takes shape
    • News

    Small cap MD buys $1 million of shares with no discount as business transformation takes shape

    In the backstretch of a business transformation that has consolidated their nationwide business and resumed shareholder dividends, one small cap Managing Director is so confident in the progress that he has personally backed the Company’s growth, purchasing $1.0 million in shares.  The show of confidence comes from Dr Chris Richards, Managing Director and CEO of

    Read More
    Public
  • «
  • ‹
  • 97
  • 98
  • 99
  • 100
  • 101
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.